cached image

Joel S. Perlmutter, M.D. - Publications

Affiliations: 
Neurology Washington University, Saint Louis, St. Louis, MO 
Area:
movement disorders, Parkinson disease, neuroimaging, dopamine, dystonia, PET
Website:
http://neuro.wustl.edu/aboutus/facultybiographies/perlmutter/

284 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Criswell SR, Nielsen SS, Warden MN, Perlmutter JS, Moerlein SM, Sheppard L, Lenox-Krug J, Checkoway H, Racette BA. [11C]dihydrotetrabenazine Positron Emission Tomography in Manganese-Exposed Workers. Journal of Occupational and Environmental Medicine. PMID 32472844 DOI: 10.1097/JOM.0000000000001915  0.84
2020 Mitchell KT, Younce JR, Norris SA, Tabbal SD, Dowling JL, Rich KM, Perlmutter JS, Ushe M. Bilateral Subthalamic Nucleus Deep Brain Stimulation in Elderly Patients With Parkinson Disease: A Case-Control Study. Operative Neurosurgery (Hagerstown, Md.). PMID 32259239 DOI: 10.1093/ons/opaa049  1
2020 Lungu C, Ozelius L, Standaert D, Hallett M, Sieber BA, Swanson-Fisher C, Berman BD, Calakos N, Moore JC, Perlmutter JS, Pirio Richardson SE, Saunders-Pullman R, Scheinfeldt L, Sharma N, Sillitoe R, et al. Defining research priorities in dystonia. Neurology. PMID 32098856 DOI: 10.1212/WNL.0000000000009140  0.44
2019 White RL, Campbell MC, Yang D, Shannon W, Snyder AZ, Perlmutter JS. Little Change in Functional Brain Networks Following Acute Levodopa in Drug-Naïve Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31854465 DOI: 10.1002/mds.27942  0.88
2019 Campbell MC, Jackson JJ, Koller JM, Snyder AZ, Kotzbauer PT, Perlmutter JS. Proteinopathy and longitudinal changes in functional connectivity networks in Parkinson disease. Neurology. PMID 31852813 DOI: 10.1212/WNL.0000000000008677  0.88
2019 Maiti B, Koller JM, Snyder AZ, Tanenbaum AB, Norris SA, Campbell MC, Perlmutter JS. Cognitive correlates of cerebellar resting-state functional connectivity in Parkinson disease. Neurology. PMID 31848257 DOI: 10.1212/WNL.0000000000008754  0.88
2019 Berman BD, Groth CL, Sillau SH, Pirio Richardson S, Norris SA, Junker J, Brüggemann N, Agarwal P, Barbano RL, Espay AJ, Vizcarra JA, Klein C, Bäumer T, Loens S, Reich SG, ... ... Perlmutter JS, et al. Risk of spread in adult-onset isolated focal dystonia: a prospective international cohort study. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 31848221 DOI: 10.1136/jnnp-2019-321794  0.44
2019 Liu H, Luo Z, Gu J, Su Y, Flores H, Parsons SM, Zhou Y, Perlmutter JS, Tu Z. The impact of dopamine D-like agonist/antagonist on [F]VAT PET measurement of VAChT in the brain of nonhuman primates. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 105152. PMID 31740395 DOI: 10.1016/j.ejps.2019.105152  0.44
2019 Yang D, Deych E, Shands B, Campbell MC, Perlmutter JS, Petersen S, Schlaggar BL, Shannon W. Detecting associations between intact connectomes and clinical covariates using recursive partitioning object-oriented data analysis. Statistics in Medicine. PMID 31650580 DOI: 10.1002/sim.8374  0.88
2019 Duncan RP, Van Dillen LR, Garbutt JM, Earhart GM, Perlmutter JS. Low Back Pain-Related Disability in Parkinson Disease: Impact on Functional Mobility, Physical Activity, and Quality of Life. Physical Therapy. PMID 31343700 DOI: 10.1093/ptj/pzz094  0.56
2019 Luo Z, Gu J, Dennett RC, Gaehle GG, Perlmutter JS, Chen DL, Benzinger TLS, Tu Z. Automated production of a sphingosine-1 phosphate receptor 1 (S1P1) PET radiopharmaceutical [C]CS1P1 for human use. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 152: 30-36. PMID 31280104 DOI: 10.1016/j.apradiso.2019.06.029  0.32
2019 Yu Y, Liang Q, Liu H, Luo Z, Hu H, Perlmutter JS, Tu Z. Development of a carbon-11 PET radiotracer for imaging TRPC5 in the brain. Organic & Biomolecular Chemistry. PMID 31115430 DOI: 10.1039/c9ob00893d  0.32
2019 Merola A, Dwivedi AK, Shaikh AG, Tareen TK, Da Prat GA, Kauffman MA, Hampf J, Mahajan A, Marsili L, Jankovic J, Comella CL, Berman BD, Perlmutter JS, Jinnah HA, Espay AJ. Head tremor at disease onset: an ataxic phenotype of cervical dystonia. Journal of Neurology. PMID 31028543 DOI: 10.1007/s00415-019-09341-w  0.44
2019 Rawson KS, McNeely ME, Duncan RP, Pickett KA, Perlmutter JS, Earhart GM. Exercise and Parkinson Disease: Comparing Tango, Treadmill, and Stretching. Journal of Neurologic Physical Therapy : Jnpt. 43: 26-32. PMID 30531383 DOI: 10.1097/NPT.0000000000000245  0.56
2018 Younce JR, Campbell MC, Perlmutter JS, Norris SA. Thalamic and ventricular volumes predict motor response to deep brain stimulation for Parkinson's disease. Parkinsonism & Related Disorders. PMID 30527905 DOI: 10.1016/j.parkreldis.2018.11.026  0.88
2018 Luo Z, Han J, Liu H, Rosenberg AJ, Chen DL, Gropler RJ, Perlmutter JS, Tu Z. Syntheses and in vitro biological evaluation of S1PR1 ligands and PET studies of four F-18 labeled radiotracers in the brain of nonhuman primates. Organic & Biomolecular Chemistry. PMID 30462126 DOI: 10.1039/c8ob02609b  0.32
2018 Gratton C, Koller JM, Shannon W, Greene DJ, Maiti B, Snyder AZ, Petersen SE, Perlmutter JS, Campbell MC. Emergent Functional Network Effects in Parkinson Disease. Cerebral Cortex (New York, N.Y. : 1991). PMID 30418543 DOI: 10.1093/cercor/bhy229  0.88
2018 Junker J, Brandt V, Berman BD, Vidailhet M, Roze E, Weissbach A, Comella C, Malaty IA, Jankovic J, LeDoux MS, Berardelli A, Barbano R, Reich SG, Perlmutter JS, Jinnah HA, et al. Predictors of alcohol responsiveness in dystonia. Neurology. PMID 30341158 DOI: 10.1212/WNL.0000000000006551  0.44
2018 Maiti B, Perlmutter JS. PET Imaging in Movement Disorders. Seminars in Nuclear Medicine. 48: 513-524. PMID 30322477 DOI: 10.1053/j.semnuclmed.2018.07.006  0.44
2018 Yue X, Luo Z, Liu H, Kaneshige K, Parsons SM, Perlmutter JS, Tu Z. Radiosynthesis and evaluation of a fluorine-18 labeled radioligand targeting vesicular acetylcholine transporter. Bioorganic & Medicinal Chemistry Letters. PMID 30274694 DOI: 10.1016/j.bmcl.2018.09.030  0.32
2018 Shimony JS, Rutlin J, Karimi M, Tian L, Snyder AZ, Loftin SK, Norris SA, Perlmutter JS. Validation of diffusion tensor imaging measures of nigrostriatal neurons in macaques. Plos One. 13: e0202201. PMID 30183721 DOI: 10.1371/journal.pone.0202201  0.72
2018 Gourisankar A, Eisenstein SA, Trapp NT, Koller JM, Campbell MC, Ushe M, Perlmutter JS, Hershey T, Black KJ. Mapping movement, mood, motivation and mentation in the subthalamic nucleus. Royal Society Open Science. 5: 171177. PMID 30109035 DOI: 10.1098/rsos.171177  1
2018 Criswell SR, Warden MN, Searles Nielsen S, Perlmutter JS, Moerlein SM, Sheppard L, Lenox-Krug J, Checkoway H, Racette BA. Selective D2 receptor PET in manganese-exposed workers. Neurology. PMID 30097475 DOI: 10.1212/WNL.0000000000006163  0.84
2018 Luo Z, Liu H, Jin H, Gu J, Yu Y, Kaneshige K, Perlmutter JS, Parsons SM, Tu Z. Exploration of new sulfur-containing analogues for imaging vesicular acetylcholine transporter in the brain. Chemmedchem. PMID 30071131 DOI: 10.1002/cmdc.201800411  0.32
2018 Gratton C, Koller JM, Shannon W, Greene DJ, Snyder AZ, Petersen SE, Perlmutter JS, Campbell MC. Emergent Functional Network Effects in Parkinson Disease. Cerebral Cortex (New York, N.Y. : 1991). PMID 29878081 DOI: 10.1093/cercor/bhy121  0.88
2018 Ibanez L, Dube U, Davis AA, Fernandez MV, Budde J, Cooper B, Diez-Fairen M, Ortega-Cubero S, Pastor P, Perlmutter JS, Cruchaga C, Benitez BA. Pleiotropic Effects of Variants in Dementia Genes in Parkinson Disease. Frontiers in Neuroscience. 12: 230. PMID 29692703 DOI: 10.3389/fnins.2018.00230  0.32
2018 Mahajan A, Jankovic J, Marsh L, Patel A, Jinnah HA, Comella C, Barbano R, Perlmutter J, Patel N. Cervical dystonia and substance abuse. Journal of Neurology. PMID 29569175 DOI: 10.1007/s00415-018-8840-9  0.44
2018 Duncan RP, Van Dillen LR, Garbutt JM, Earhart GM, Perlmutter JS. Physical therapy and deep brain stimulation in Parkinson's Disease: protocol for a pilot randomized controlled trial. Pilot and Feasibility Studies. 4: 54. PMID 29484198 DOI: 10.1186/s40814-018-0243-2  0.56
2018 Morris AE, Norris SA, Perlmutter JS, Mink JW. Quantitative, clinically relevant acoustic measurements of focal embouchure dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29460980 DOI: 10.1002/mds.27298  0.84
2018 Liu H, Jin H, Luo Z, Yue X, Zhang X, Flores H, Su Y, Perlmutter JS, Tu Z. In vivo characterization of two 18F-labeled PDE10A PET radioligands in nonhuman primate brains. Acs Chemical Neuroscience. PMID 29400443 DOI: 10.1021/acschemneuro.7b00458  0.44
2018 Milchenko M, Norris SA, Poston K, Campbell MC, Ushe M, Perlmutter JS, Snyder AZ. 7T MRI subthalamic nucleus atlas for use with 3T MRI. Journal of Medical Imaging (Bellingham, Wash.). 5: 015002. PMID 29340288 DOI: 10.1117/1.JMI.5.1.015002  1
2018 Jin H, Yue X, Liu H, Han J, Flores H, Su Y, Parsons SM, Perlmutter JS, Tu Z. Kinetic modeling of [18 F]VAT, a novel radioligand for PET imaging vesicular acetylcholine transporter (VAChT) in nonhuman primate brain. Journal of Neurochemistry. PMID 29315563 DOI: 10.1111/jnc.14291  0.44
2017 Jin H, Han J, Resing D, Liu H, Yue X, Miller RL, Schoch KM, Miller TM, Perlmutter JS, Egan TM, Tu Z. Synthesis and in vitro characterization of a P2×7 radioligand [123I]TZ6019 and its response to neuroinflammatory in a mouse model of Alzheimer Disease. European Journal of Pharmacology. PMID 29225193 DOI: 10.1016/j.ejphar.2017.12.006  0.32
2017 Ibanez L, Dube U, Saef B, Budde J, Black K, Medvedeva A, Del-Aguila JL, Davis AA, Perlmutter JS, Harari O, Benitez BA, Cruchaga C. Parkinson disease polygenic risk score is associated with Parkinson disease status and age at onset but not with alpha-synuclein cerebrospinal fluid levels. Bmc Neurology. 17: 198. PMID 29141588 DOI: 10.1186/s12883-017-0978-z  0.32
2017 Norris SA, Pogarcic A, Hicks M, Perlmutter JS, Shinawi M. Adult-onset dystonia with marfanoid features. Neurology. Clinical Practice. 7: e31-e34. PMID 28840904 DOI: 10.1212/CPJ.0000000000000297  0.44
2017 Criswell SR, Nielsen SS, Warden M, Perlmutter JS, Moerlein SM, Flores HP, Huang J, Sheppard L, Seixas N, Checkoway H, Racette BA. [(18)F]FDOPA Positron Emission Tomography in Manganese-Exposed Workers. Neurotoxicology. PMID 28694016 DOI: 10.1016/j.neuro.2017.07.004  0.84
2017 Yue X, Jin H, Liu H, Luo Z, Zhang X, Kaneshige K, Flores HP, Perlmutter JS, Parsons SM, Tu Z. Synthesis, resolution, and in vitro evaluation of three vesicular acetylcholine transporter ligands and evaluation of the lead fluorine-18 radioligand in a nonhuman primate. Organic & Biomolecular Chemistry. PMID 28590490 DOI: 10.1039/c7ob00854f  0.44
2017 Pirio Richardson S, Altenmüller E, Alter K, Alterman RL, Chen R, Frucht S, Furuya S, Jankovic J, Jinnah HA, Kimberley TJ, Lungu C, Perlmutter JS, Prudente CN, Hallett M. Research Priorities in Limb and Task-Specific Dystonias. Frontiers in Neurology. 8: 170. PMID 28515706 DOI: 10.3389/fneur.2017.00170  0.44
2017 Berman BD, Junker J, Shelton E, Sillau SH, Jinnah HA, Perlmutter JS, Espay AJ, Jankovic J, Vidailhet M, Bonnet C, Ondo W, Malaty IA, Rodríguez R, McDonald WM, Marsh L, et al. Psychiatric associations of adult-onset focal dystonia phenotypes. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 28438790 DOI: 10.1136/jnnp-2016-315461  0.44
2017 Han J, Liu H, Liu C, Jin H, Perlmutter JS, Egan TM, Tu Z. Pharmacologic characterizations of a P2X7 receptor-specific radioligand, [11C]GSK1482160 for neuroinflammatory response. Nuclear Medicine Communications. PMID 28338530 DOI: 10.1097/MNM.0000000000000660  0.32
2017 Martin WR, Hartlein J, Racette BA, Cairns N, Perlmutter JS. Pathologic correlates of supranuclear gaze palsy with parkinsonism. Parkinsonism & Related Disorders. PMID 28256434 DOI: 10.1016/j.parkreldis.2017.02.027  0.84
2017 Yue X, Jin H, Luo Z, Liu H, Zhang X, McSpadden ED, Tian L, Flores HP, Perlmutter JS, Parsons SM, Tu Z. Chiral resolution of serial potent and selective σ1 ligands and biological evaluation of (-)-[(18)F]TZ3108 in rodent and the nonhuman primate brain. Bioorganic & Medicinal Chemistry. PMID 28129990 DOI: 10.1016/j.bmc.2017.01.017  0.44
2016 Eisenstein SA, Bogdan R, Chen L, Moerlein SM, Black KJ, Perlmutter JS, Hershey T, Barch DM. Preliminary evidence that negative symptom severity relates to multilocus genetic profile for dopamine signaling capacity and D2 receptor binding in healthy controls and in schizophrenia. Journal of Psychiatric Research. 86: 9-17. PMID 27886638 DOI: 10.1016/j.jpsychires.2016.11.007  0.88
2016 Peterson DA, Littlewort GC, Bartlett MS, Macerollo A, Perlmutter JS, Jinnah HA, Hallett M, Sejnowski TJ. Objective, computerized video-based rating of blepharospasm severity. Neurology. PMID 27770067 DOI: 10.1212/WNL.0000000000003336  0.44
2016 Liu H, Jin H, Yue X, Han J, Yang H, Flores H, Su Y, Alagille D, Perlmutter JS, Tamagnan G, Tu Z. Comparison of [(11)C]TZ1964B and [(18)F]MNI659 for PET imaging brain PDE10A in nonhuman primates. Pharmacology Research & Perspectives. 4: e00253. PMID 27713824 DOI: 10.1002/prp2.253  0.44
2016 Pepino MY, Eisenstein SA, Bischoff AN, Klein S, Moerlein SM, Perlmutter JS, Black KJ, Hershey T. Sweet dopamine: Sucrose preferences relate differentially to striatal D2 receptor binding and age in obesity. Diabetes. PMID 27307220 DOI: 10.2337/db16-0407  0.88
2016 Eisenstein SA, Bogdan R, Love-Gregory L, Corral-Frías NS, Koller JM, Black KJ, Moerlein SM, Perlmutter JS, Barch DM, Hershey T. Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status. Synapse (New York, N.Y.). PMID 27241797 DOI: 10.1002/syn.21916  0.56
2016 LeDoux MS, Vemula SR, Xiao J, Thompson MM, Perlmutter JS, Wright LJ, Jinnah HA, Rosen AR, Hedera P, Comella CL, Weissbach A, Junker J, Jankovic J, Barbano RL, Reich SG, et al. Clinical and genetic features of cervical dystonia in a large multicenter cohort. Neurology. Genetics. 2: e69. PMID 27123488 DOI: 10.1212/NXG.0000000000000069  0.44
2016 Carlozzi NE, Schilling SG, Lai JS, Perlmutter JS, Nance MA, Waljee JF, Miner JA, Barton SK, Goodnight SM, Dayalu P. HDQLIFE: the development of two new computer adaptive tests for use in Huntington disease, Speech Difficulties, and Swallowing Difficulties. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. PMID 27038054 DOI: 10.1007/s11136-016-1273-y  1
2016 Jin H, Zhang X, Yue X, Liu H, Li J, Yang H, Flores H, Su Y, Parsons SM, Perlmutter JS, Tu Z. Kinetics modeling and occupancy studies of a novel C-11 PET tracer for VAChT in nonhuman primates. Nuclear Medicine and Biology. 43: 131-9. PMID 26872437 DOI: 10.1016/j.nucmedbio.2015.11.003  1
2016 Carvalho JO, Long JD, Westervelt HJ, Smith MM, Bruce JM, Kim JI, Mills JA, Paulsen JS, The Predict-Hd Investigators And Coordinators Of The Huntington Study Group. The impact of oculomotor functioning on neuropsychological performance in Huntington disease. Journal of Clinical and Experimental Neuropsychology. 38: 217-226. PMID 26745770 DOI: 10.1080/13803395.2015.1101054  1
2016 Eisenstein SA, Gredysa DM, Antenor-Dorsey JA, Green L, Arbeláez AM, Koller JM, Black KJ, Perlmutter JS, Moerlein SM, Hershey T. Correction: Insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in Obesity. Plos One. 11: e0147063. PMID 26744894 DOI: 10.1371/journal.pone.0147063  0.88
2015 Siddiqi SH, Abraham NK, Geiger CL, Karimi M, Perlmutter JS, Black KJ. The Human Experience with Intravenous Levodopa. Frontiers in Pharmacology. 6: 307. PMID 26779024 DOI: 10.3389/fphar.2015.00307  1
2015 Karimi M, Tu Z, Yue X, Zhang X, Jin H, Perlmutter JS, Laforest R. Radiation dosimetry of [(18)F]VAT in nonhuman primates. Ejnmmi Research. 5: 73. PMID 26660544 DOI: 10.1186/s13550-015-0149-4  1
2015 Davis AA, Andruska KM, Benitez BA, Racette BA, Perlmutter JS, Cruchaga C. Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression. Neurobiology of Aging. PMID 26601739 DOI: 10.1016/j.neurobiolaging.2015.09.014  1
2015 Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, ... ... Perlmutter JS, et al. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. Jama Neurology. 1-9. PMID 26569098 DOI: 10.1001/jamaneurol.2015.2736  0.4
2015 Buddhala C, Loftin SK, Kuley BM, Cairns NJ, Campbell MC, Perlmutter JS, Kotzbauer PT. Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease. Annals of Clinical and Translational Neurology. 2: 949-59. PMID 26478895 DOI: 10.1002/acn3.246  0.88
2015 Li J, Zhang X, Jin H, Fan J, Flores H, Perlmutter JS, Tu Z. Synthesis of fluorine-containing phosphodiesterase 10A (PDE10A) inhibitors and the in vivo evaluation of F-18 labeled PDE10A PET tracers in rodent and nonhuman primate. Journal of Medicinal Chemistry. PMID 26430878 DOI: 10.1021/acs.jmedchem.5b01205  1
2015 Yue X, Bognar C, Zhang X, Gaehle GG, Moerlein SM, Perlmutter JS, Tu Z. Automated production of [(18)F]VAT suitable for clinical PET study of vesicular acetylcholine transporter. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 107: 40-46. PMID 26408913 DOI: 10.1016/j.apradiso.2015.09.010  1
2015 Long JD, Paulsen JS. Multivariate prediction of motor diagnosis in Huntington's disease: 12 years of PREDICT-HD. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26340420 DOI: 10.1002/mds.26364  1
2015 Liu H, Jin H, Yue X, Zhang X, Yang H, Li J, Flores H, Su Y, Perlmutter JS, Tu Z. Preclinical evaluation of a promising C-11 labeled PET tracer for imaging phosphodiesterase10A in the brain of living subject. Neuroimage. PMID 26216275 DOI: 10.1016/j.neuroimage.2015.07.049  1
2015 Eisenstein SA, Gredysa DM, Antenor-Dorsey JA, Green L, Arbeláez AM, Koller JM, Black KJ, Perlmutter JS, Moerlein SM, Hershey T. Insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in Obesity. Plos One. 10: e0133621. PMID 26192187 DOI: 10.1371/journal.pone.0133621  1
2015 Matsui JT, Vaidya JG, Wassermann D, Kim RE, Magnotta VA, Johnson HJ, Paulsen JS. Prefrontal cortex white matter tracts in prodromal Huntington disease. Human Brain Mapping. 36: 3717-32. PMID 26179962 DOI: 10.1002/hbm.22835  1
2015 Tu Z, Zhang X, Jin H, Yue X, Padakanti PK, Yu L, Liu H, Flores HP, Kaneshige K, Parsons SM, Perlmutter JS. Synthesis and biological characterization of a promising F-18 PET tracer for vesicular acetylcholine transporter. Bioorganic & Medicinal Chemistry. PMID 26138195 DOI: 10.1016/j.bmc.2015.05.058  1
2015 Tian L, Xia Y, Flores HP, Campbell MC, Moerlein SM, Perlmutter JS. Neuroimaging Analysis of the Dopamine Basis for Apathetic Behaviors in an MPTP-Lesioned Primate Model. Plos One. 10: e0132064. PMID 26135399 DOI: 10.1371/journal.pone.0132064  1
2015 Eisenstein SA, Bischoff AN, Gredysa DM, Antenor-Dorsey JA, Koller JM, Al-Lozi A, Pepino MY, Klein S, Perlmutter JS, Moerlein SM, Black KJ, Hershey T. Emotional Eating Phenotype is Associated with Central Dopamine D2 Receptor Binding Independent of Body Mass Index. Scientific Reports. 5: 11283. PMID 26066863 DOI: 10.1038/srep11283  1
2015 Lucero C, Campbell MC, Flores H, Maiti B, Perlmutter JS, Foster ER. Cognitive reserve and β-amyloid pathology in Parkinson disease. Parkinsonism & Related Disorders. PMID 26037458 DOI: 10.1016/j.parkreldis.2015.05.020  1
2015 Kim JI, Long JD, Mills JA, McCusker E, Paulsen JS. Multivariate Clustering of Progression Profiles Reveals Different Depression Patterns in Prodromal Huntington Disease. Neuropsychology. PMID 26011117 DOI: 10.1037/neu0000199  1
2015 Campbell MC, Koller JM, Snyder AZ, Buddhala C, Kotzbauer PT, Perlmutter JS. CSF proteins and resting-state functional connectivity in Parkinson disease. Neurology. 84: 2413-21. PMID 25979701 DOI: 10.1212/WNL.0000000000001681  1
2015 Stewart SB, Koller JM, Campbell MC, Perlmutter JS, Black KJ. Additive global cerebral blood flow normalization in arterial spin labeling perfusion imaging. Peerj. 3: e834. PMID 25802806 DOI: 10.7717/peerj.834  1
2015 Liu H, Jin H, Li J, Zhang X, Kaneshige K, Parsons SM, Perlmutter JS, Tu Z. In vitro and ex vivo characterization of (-)-TZ659 as a ligand for imaging the vesicular acetylcholine transporter. European Journal of Pharmacology. 752: 18-25. PMID 25678250 DOI: 10.1016/j.ejphar.2015.02.001  1
2015 Earhart GM, Duncan RP, Huang JL, Perlmutter JS, Pickett KA. Comparing interventions and exploring neural mechanisms of exercise in Parkinson disease: a study protocol for a randomized controlled trial. Bmc Neurology. 15: 9. PMID 25652002 DOI: 10.1186/s12883-015-0261-0  1
2015 Yan L, Hicks M, Winslow K, Comella C, Ludlow C, Jinnah HA, Rosen AR, Wright L, Galpern WR, Perlmutter JS. Secured web-based video repository for multicenter studies. Parkinsonism & Related Disorders. 21: 366-71. PMID 25630890 DOI: 10.1016/j.parkreldis.2015.01.011  1
2015 Wippold FJ, Brown DC, Broderick DF, Burns J, Corey AS, Deshmukh TK, Douglas AC, Holloway K, Jagadeesan BD, Jurgens JS, Kennedy TA, Patel ND, Perlmutter JS, Rosenow JM, Slavin K, et al. ACR Appropriateness Criteria Dementia and Movement Disorders. Journal of the American College of Radiology : Jacr. 12: 19-28. PMID 25557568 DOI: 10.1016/j.jacr.2014.09.025  1
2015 Buddhala C, Campbell MC, Perlmutter JS, Kotzbauer PT. Correlation between decreased CSF α-synuclein and Aβ₁₋₄₂ in Parkinson disease. Neurobiology of Aging. 36: 476-84. PMID 25212463 DOI: 10.1016/j.neurobiolaging.2014.07.043  1
2015 Norris SA, Derdeyn CP, Perlmutter JS. Levodopa-Responsive Hemiparkinsonism Secondary to Cystic Expansion from a Coiled Cerebral Aneurysm Journal of Neuroimaging. 25: 316-318. DOI: 10.1111/jon.12117  1
2015 Musso M, Westervelt HJ, Long JD, Morgan E, Woods SP, Smith MM, Lu W, Paulsen JS, Cross S, Ryan P, Epping EA, Chiu E, Preston J, Goh A, Antonopoulos S, ... ... Perlmutter J, et al. Intra-individual variability in prodromal Huntington disease and its relationship to genetic burden Journal of the International Neuropsychological Society. 21: 8-21. DOI: 10.1017/S1355617714001076  1
2014 Jin H, Fan J, Zhang X, Li J, Flores HP, Perlmutter JS, Parsons SM, Tu Z. Radiosynthesis and in vivo evaluation of a novel σ1 selective PET ligand. Medchemcomm. 5: 1669-1677. PMID 25584182 DOI: 10.1039/C4MD00240G  1
2014 Perlmutter JS, Norris SA. Neuroimaging biomarkers for Parkinson disease: Facts and fantasy Annals of Neurology. 76: 769-783. PMID 25363872 DOI: 10.1002/ana.24291  1
2014 Hershey LA, Perlmutter JS. Smoking and Parkinson disease: Where there is smoke there may not be fire Neurology. 83: 1392-1393. PMID 25217061 DOI: 10.1212/WNL.0000000000000896  1
2014 Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, DeStefano AL, Kara E, Bras J, Sharma M, Schulte C, Keller MF, Arepalli S, Letson C, Edsall C, ... ... Perlmutter JS, et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nature Genetics. 46: 989-93. PMID 25064009 DOI: 10.1038/ng.3043  1
2014 Dugan LL, Tian L, Quick KL, Hardt JI, Karimi M, Brown C, Loftin S, Flores H, Moerlein SM, Polich J, Tabbal SD, Mink JW, Perlmutter JS. Carboxyfullerene neuroprotection postinjury in Parkinsonian nonhuman primates. Annals of Neurology. 76: 393-402. PMID 25043598 DOI: 10.1002/ana.24220  1
2014 Eisenstein SA, Dewispelaere WB, Campbell MC, Lugar HM, Perlmutter JS, Black KJ, Hershey T. Acute changes in mood induced by subthalamic deep brain stimulation in Parkinson disease are modulated by psychiatric diagnosis. Brain Stimulation. 7: 701-8. PMID 25017671 DOI: 10.1016/j.brs.2014.06.002  1
2014 Eisenstein SA, Koller JM, Black KD, Campbell MC, Lugar HM, Ushe M, Tabbal SD, Karimi M, Hershey T, Perlmutter JS, Black KJ. Functional anatomy of subthalamic nucleus stimulation in Parkinson disease. Annals of Neurology. 76: 279-95. PMID 24953991 DOI: 10.1002/ana.24204  1
2014 Vemula SR, Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Truong DD, Blitzer A, Rudzi?ska M, Mom?ilovi? D, et al. A rare sequence variant in intron 1 of THAP1 is associated with primary dystonia. Molecular Genetics & Genomic Medicine. 2: 261-72. PMID 24936516 DOI: 10.1002/mgg3.67  0.84
2014 Perlmutter JS. Comment: FMRI biomarker for premanifest HD? Neurology. 83: 71. PMID 24898927 DOI: 10.1212/WNL.0000000000000553  1
2014 Padakanti PK, Zhang X, Li J, Parsons SM, Perlmutter JS, Tu Z. Syntheses and radiosyntheses of two carbon-11 labeled potent and selective radioligands for imaging vesicular acetylcholine transporter. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 16: 765-72. PMID 24875230 DOI: 10.1007/s11307-014-0748-x  1
2014 Padakanti PK, Zhang X, Jin H, Cui J, Wang R, Li J, Flores HP, Parsons SM, Perlmutter JS, Tu Z. In vitro and in vivo characterization of two C-11-labeled pet tracers for vesicular acetylcholine transporter. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 16: 773-80. PMID 24865402 DOI: 10.1007/s11307-014-0749-9  1
2014 Tian L, Karimi M, Brown CA, Loftin SK, Perlmutter JS. In vivo measures of nigrostriatal neuronal response to unilateral MPTP treatment. Brain Research. 1571: 49-60. PMID 24845719 DOI: 10.1016/j.brainres.2014.05.009  1
2014 Paulsen JS, Long JD, Johnson HJ, Aylward EH, Ross CA, Williams JK, Nance MA, Erwin CJ, Westervelt HJ, Harrington DL, Bockholt HJ, Zhang Y, McCusker EA, Chiu EM, Panegyres PK, et al. Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study. Frontiers in Aging Neuroscience. 6: 78. PMID 24795630 DOI: 10.3389/fnagi.2014.00078  1
2014 Fan J, Zhang X, Li J, Jin H, Padakanti PK, Jones LA, Flores HP, Su Y, Perlmutter JS, Tu Z. Radiosyntheses and in vivo evaluation of carbon-11 PET tracers for PDE10A in the brain of rodent and nonhuman primate Bioorganic and Medicinal Chemistry. 22: 2648-2654. PMID 24721831 DOI: 10.1016/j.bmc.2014.03.028  1
2014 Semrau JA, Perlmutter JS, Thoroughman KA. Visuomotor adaptation in Parkinson's disease: effects of perturbation type and medication state. Journal of Neurophysiology. 111: 2675-87. PMID 24694937 DOI: 10.1152/jn.00095.2013  1
2014 Peterson DS, Pickett KA, Duncan R, Perlmutter J, Earhart GM. Gait-related brain activity in people with Parkinson disease with freezing of gait. Plos One. 9: e90634. PMID 24595265 DOI: 10.1371/journal.pone.0090634  1
2014 Black KJ, Snyder AZ, Mink JW, Tolia VN, Revilla FJ, Moerlein SM, Perlmutter JS. Spatial reorganization of putaminal dopamine D2-like receptors in cranial and hand dystonia. Plos One. 9: e88121. PMID 24520350 DOI: 10.1371/journal.pone.0088121  1
2014 Willis AW, Schootman M, Kung N, Wang XY, Perlmutter JS, Racette BA. Disparities in deep brain stimulation surgery among insured elders with Parkinson disease. Neurology. 82: 163-71. PMID 24336138 DOI: 10.1212/WNL.0000000000000017  1
2014 Peterson DS, Pickett KA, Duncan RP, Perlmutter JS, Earhart GM. Brain activity during complex imagined gait tasks in Parkinson disease. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 125: 995-1005. PMID 24210997 DOI: 10.1016/j.clinph.2013.10.008  1
2014 Long JD, Paulsen JS, Marder K, Zhang Y, Kim JI, Mills JA. Tracking motor impairments in the progression of Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 311-9. PMID 24150908 DOI: 10.1002/mds.25657  1
2014 Armstrong RA, Kotzbauer PT, Perlmutter JS, Campbell MC, Hurth KM, Schmidt RE, Cairns NJ. A quantitative study of α-synuclein pathology in fifteen cases of dementia associated with Parkinson disease. Journal of Neural Transmission (Vienna, Austria : 1996). 121: 171-81. PMID 23996276 DOI: 10.1007/s00702-013-1084-z  1
2014 Younes L, Ratnanather JT, Brown T, Aylward E, Nopoulos P, Johnson H, Magnotta VA, Paulsen JS, Margolis RL, Albin RL, Miller MI, Ross CA. Regionally selective atrophy of subcortical structures in prodromal HD as revealed by statistical shape analysis. Human Brain Mapping. 35: 792-809. PMID 23281100 DOI: 10.1002/hbm.22214  1
2013 Karimi M, Moerlein SM, Videen TO, Su Y, Flores HP, Perlmutter JS. Striatal dopamine D1-like receptor binding is unchanged in primary focal dystonia Movement Disorders. 28: 2002-2006. PMID 24151192 DOI: 10.1002/mds.25720  1
2013 Jinnah HA, Berardelli A, Comella C, Defazio G, Delong MR, Factor S, Galpern WR, Hallett M, Ludlow CL, Perlmutter JS, Rosen AR. The focal dystonias: current views and challenges for future research. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 926-43. PMID 23893450 DOI: 10.1002/mds.25567  1
2013 Campbell MC, Markham J, Flores H, Hartlein JM, Goate AM, Cairns NJ, Videen TO, Perlmutter JS. Principal component analysis of PiB distribution in Parkinson and Alzheimer diseases. Neurology. 81: 520-7. PMID 23825179 DOI: 10.1212/WNL.0b013e31829e6f94  1
2013 Li J, Zhang X, Zhang Z, Padakanti PK, Jin H, Cui J, Li A, Zeng D, Rath NP, Flores H, Perlmutter JS, Parsons SM, Tu Z. Heteroaromatic and aniline derivatives of piperidines as potent ligands for vesicular acetylcholine transporter. Journal of Medicinal Chemistry. 56: 6216-33. PMID 23802889 DOI: 10.1021/jm400664x  1
2013 Sun J, Cairns NJ, Perlmutter JS, Mach RH, Xu J. Regulation of dopamine D₃ receptor in the striatal regions and substantia nigra in diffuse Lewy body disease. Neuroscience. 248: 112-26. PMID 23732230 DOI: 10.1016/j.neuroscience.2013.05.048  1
2013 Brown CA, Karimi MK, Tian L, Flores H, Su Y, Tabbal SD, Loftin SK, Moerlein SM, Perlmutter JS. Validation of midbrain positron emission tomography measures for nigrostriatal neurons in macaques. Annals of Neurology. 74: 602-10. PMID 23686841 DOI: 10.1002/ana.23939  1
2013 Snyder AZ, Perlmutter JS, Hacker CD. Reply: Levodopa increases functional connectivity in the cerebellum and brainstem in Parkinson's disease Brain. 136: e235. PMID 23650223 DOI: 10.1093/brain/awt016  1
2013 Eisenstein SA, Antenor-Dorsey JA, Gredysa DM, Koller JM, Bihun EC, Ranck SA, Arbeláez AM, Klein S, Perlmutter JS, Moerlein SM, Black KJ, Hershey T. A comparison of D2 receptor specific binding in obese and normal-weight individuals using PET with (N-[(11)C]methyl)benperidol. Synapse (New York, N.Y.). 67: 748-56. PMID 23650017 DOI: 10.1002/syn.21680  1
2013 Karimi M, Tian L, Brown CA, Flores HP, Loftin SK, Videen TO, Moerlein SM, Perlmutter JS. Validation of nigrostriatal positron emission tomography measures: critical limits. Annals of Neurology. 73: 390-6. PMID 23423933 DOI: 10.1002/ana.23798  1
2013 Ushe M, Perlmutter JS. Sex, drugs and Parkinson's disease. Brain : a Journal of Neurology. 136: 371-3. PMID 23413258 DOI: 10.1093/brain/awt022  1
2013 Bagchi DP, Yu L, Perlmutter JS, Xu J, Mach RH, Tu Z, Kotzbauer PT. Binding of the Radioligand SIL23 to α-Synuclein Fibrils in Parkinson Disease Brain Tissue Establishes Feasibility and Screening Approaches for Developing a Parkinson Disease Imaging Agent Plos One. 8. PMID 23405108 DOI: 10.1371/journal.pone.0055031  1
2013 Xu J, Vangveravong S, Li S, Fan J, Jones LA, Cui J, Wang R, Tu Z, Chu W, Perlmutter JS, Mach RH. Positron emission tomography imaging of dopamine D2 receptors using a highly selective radiolabeled D2 receptor partial agonist Neuroimage. 71: 168-174. PMID 23333701 DOI: 10.1016/j.neuroimage.2013.01.007  1
2013 Hill KK, Campbell MC, McNeely ME, Karimi M, Ushe M, Tabbal SD, Hershey T, Flores HP, Hartlein JM, Lugar HM, Revilla FJ, Videen TO, Earhart GM, Perlmutter JS. Cerebral blood flow responses to dorsal and ventral STN DBS correlate with gait and balance responses in Parkinson's disease. Experimental Neurology. 241: 105-12. PMID 23262122 DOI: 10.1016/j.expneurol.2012.12.003  1
2013 Harms MB, Neumann D, Benitez BA, Cooper B, Carrell D, Racette BA, Perlmutter JS, Goate A, Cruchaga C. Parkinson disease is not associated with C9ORF72 repeat expansions. Neurobiology of Aging. 34: 1519.e1-2. PMID 23116878 DOI: 10.1016/j.neurobiolaging.2012.10.001  1
2012 Ushe M, Perlmutter JS. Oromandibular and lingual dystonia associated with spinocerebellar ataxia type 8. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1741-2. PMID 23283653 DOI: 10.1002/mds.25295  1
2012 Hacker CD, Perlmutter JS, Criswell SR, Ances BM, Snyder AZ. Resting state functional connectivity of the striatum in Parkinson's disease. Brain : a Journal of Neurology. 135: 3699-711. PMID 23195207 DOI: 10.1093/brain/aws281  1
2012 Sun J, Xu J, Cairns NJ, Perlmutter JS, Mach RH. Dopamine D1, D2, D3 receptors, vesicular monoamine transporter type-2 (VMAT2) and dopamine transporter (DAT) densities in aged human brain. Plos One. 7: e49483. PMID 23185343 DOI: 10.1371/journal.pone.0049483  1
2012 Willis AW, Schootman M, Tran R, Kung N, Evanoff BA, Perlmutter JS, Racette BA. Neurologist-associated reduction in PD-related hospitalizations and health care expenditures. Neurology. 79: 1774-80. PMID 23054239 DOI: 10.1212/WNL.0b013e3182703f92  1
2012 Racette BA, Criswell SR, Lundin JI, Hobson A, Seixas N, Kotzbauer PT, Evanoff BA, Perlmutter JS, Zhang J, Sheppard L, Checkoway H. Increased risk of parkinsonism associated with welding exposure. Neurotoxicology. 33: 1356-61. PMID 22975422 DOI: 10.1016/j.neuro.2012.08.011  1
2012 Tabbal SD, Tian L, Karimi M, Brown CA, Loftin SK, Perlmutter JS. Low nigrostriatal reserve for motor parkinsonism in nonhuman primates. Experimental Neurology. 237: 355-62. PMID 22836146 DOI: 10.1016/j.expneurol.2012.07.008  1
2012 Kotzbauer PT, Cairns NJ, Campbell MC, Willis AW, Racette BA, Tabbal SD, Perlmutter JS. Pathologic accumulation of α-synuclein and Aβ in Parkinson disease patients with dementia. Archives of Neurology. 69: 1326-31. PMID 22825369 DOI: 10.1001/archneurol.2012.1608  1
2012 Lee JK, Mathews K, Schlaggar B, Perlmutter J, Paulsen JS, Epping E, Burmeister L, Nopoulos P. Measures of growth in children at risk for Huntington disease. Neurology. 79: 668-74. PMID 22815549 DOI: 10.1212/WNL.0b013e3182648b65  1
2012 Brown CA, Campbell MC, Karimi M, Tabbal SD, Loftin SK, Tian LL, Moerlein SM, Perlmutter JS. Dopamine pathway loss in nucleus accumbens and ventral tegmental area predicts apathetic behavior in MPTP-lesioned monkeys. Experimental Neurology. 236: 190-7. PMID 22579525 DOI: 10.1016/j.expneurol.2012.04.025  1
2012 Eisenstein SA, Koller JM, Piccirillo M, Kim A, Antenor-Dorsey JA, Videen TO, Snyder AZ, Karimi M, Moerlein SM, Black KJ, Perlmutter JS, Hershey T. Characterization of extrastriatal D2 in vivo specific binding of [¹⁸F](N-methyl)benperidol using PET. Synapse (New York, N.Y.). 66: 770-80. PMID 22535514 DOI: 10.1002/syn.21566  1
2012 Campbell MC, Black KJ, Weaver PM, Lugar HM, Videen TO, Tabbal SD, Karimi M, Perlmutter JS, Hershey T. Mood response to deep brain stimulation of the subthalamic nucleus in Parkinson's disease. The Journal of Neuropsychiatry and Clinical Neurosciences. 24: 28-36. PMID 22450611 DOI: 10.1176/appi.neuropsych.11030060  1
2012 Xiao J, Uitti RJ, Zhao Y, Vemula SR, Perlmutter JS, Wszolek ZK, Maraganore DM, Auburger G, Leube B, Lehnhoff K, LeDoux MS. Mutations in CIZ1 cause adult onset primary cervical dystonia. Annals of Neurology. 71: 458-69. PMID 22447717 DOI: 10.1002/ana.23547  1
2012 Criswell SR, Perlmutter JS, Huang JL, Golchin N, Flores HP, Hobson A, Aschner M, Erikson KM, Checkoway H, Racette BA. Basal ganglia intensity indices and diffusion weighted imaging in manganese-exposed welders. Occupational and Environmental Medicine. 69: 437-43. PMID 22447645 DOI: 10.1136/oemed-2011-100119  1
2012 Criswell SR, Perlmutter JS, Crippin JS, Videen TO, Moerlein SM, Flores HP, Birke AM, Racette BA. Reduced uptake of FDOPA PET in end-stage liver disease with elevated manganese levels. Archives of Neurology. 69: 394-7. PMID 22410448 DOI: 10.1001/archneurol.2011.771  1
2012 Tian L, Karimi M, Loftin SK, Brown CA, Xia H, Xu J, Mach RH, Perlmutter JS. No differential regulation of dopamine transporter (DAT) and vesicular monoamine transporter 2 (VMAT2) binding in a primate model of Parkinson disease. Plos One. 7: e31439. PMID 22359591 DOI: 10.1371/journal.pone.0031439  1
2012 Perlmutter JS, Eidelberg D. To scan or not to scan: DaT is the question Neurology. 78: 688-689. PMID 22323757 DOI: 10.1212/WNL.0b013e3182494c72  1
2012 Willis AW, Schootman M, Kung N, Evanoff BA, Perlmutter JS, Racette BA. Predictors of survival in patients with Parkinson disease. Archives of Neurology. 69: 601-7. PMID 22213411 DOI: 10.1001/archneurol.2011.2370  1
2011 Brenner SR. Reduced uptake of [18F]FDOPA PET in asymptomatic welders with occupational manganese exposure. Neurology. 77: e120; author reply e. PMID 22084283 DOI: 10.1212/WNL.0b013e318239bfeb  1
2011 Nopoulos P, Epping EA, Wassink T, Schlaggar BL, Perlmutter J. Correlation of CAG repeat length between the maternal and paternal allele of the Huntingtin gene: evidence for assortative mating. Behavioral and Brain Functions : Bbf. 7: 45. PMID 22008211 DOI: 10.1186/1744-9081-7-45  1
2011 Willis AW, Schootman M, Evanoff BA, Perlmutter JS, Racette BA. Neurologist care in Parkinson disease: A utilization, outcomes, and survival study Neurology. 77: 851-857. PMID 21832214 DOI: 10.1212/WNL.0b013e31822c9123  1
2011 McNeely ME, Hershey T, Campbell MC, Tabbal SD, Karimi M, Hartlein JM, Lugar HM, Revilla FJ, Perlmutter JS, Earhart GM. Effects of deep brain stimulation of dorsal versus ventral subthalamic nucleus regions on gait and balance in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 1250-5. PMID 21478202 DOI: 10.1136/jnnp.2010.232900  1
2011 Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Simon DK, Tarsy D, Hedera P, Truong DD, et al. The c.-237_236GA>TT THAP1 sequence variant does not increase risk for primary dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 549-52. PMID 21370264 DOI: 10.1002/mds.23551  1
2011 Tu Z, Fan J, Li S, Jones LA, Cui J, Padakanti PK, Xu J, Zeng D, Shoghi KI, Perlmutter JS, MacH RH. Radiosynthesis and in vivo evaluation of [ 11C]MP-10 as a PET probe for imaging PDE10A in rodent and non-human primate brain Bioorganic and Medicinal Chemistry. 19: 1666-1673. PMID 21315609 DOI: 10.1016/j.bmc.2011.01.032  1
2011 Powers WJ, Videen TO, Markham J, Walter V, Perlmutter JS. Metabolic control of resting hemispheric cerebral blood flow is oxidative, not glycolytic Journal of Cerebral Blood Flow and Metabolism. 31: 1223-1228. PMID 21304554 DOI: 10.1038/jcbfm.2011.5  1
2011 Mach RH, Tu Z, Xu J, Li S, Jones LA, Taylor M, Luedtke RR, Derdeyn CP, Perlmutter JS, Mintun MA. Endogenous dopamine (DA) competes with the binding of a radiolabeled D3 receptor partial agonist in vivo: A positron emission tomography study Synapse. 65: 724-732. PMID 21132811 DOI: 10.1002/syn.20891  1
2011 Karimi M, Moerlein SM, Videen TO, Luedtke RR, Taylor M, Mach RH, Perlmutter JS. Decreased striatal dopamine receptor binding in primary focal dystonia: A D2 or D3 defect? Movement Disorders. 26: 100-106. PMID 20960437 DOI: 10.1002/mds.23401  1
2011 Powers WJ, Haas RH, Le T, Videen TO, Markham J, Perlmutter JS. Platelet mitochondrial complex i and IIII activities do not correlate with cerebral mitochondrial oxidative metabolism Journal of Cerebral Blood Flow and Metabolism. 31: e1-e5. PMID 20959851 DOI: 10.1038/jcbfm.2010.179  1
2011 Karimi M, Perlmutter JS. MRI measures predict progressive supranuclear palsy: Clinically useful? Neurology. 77: 1028-1029. DOI: 10.1212/WNL.0b013e31822e14c7  1
2011 Criswell SR, Perlmutter JS, Videen TO, Moerlein SM, Flores HP, Birke AM, Racette BA. Reduced uptake of [18F]FDOPA PET in asymptomatic welders with occupational manganese exposure Neurology. 76: 1296-1301. DOI: 10.1212/WNL.0b013e3182152830  1
2010 Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, et al. Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. Human Genetics. 127: 470. PMID 21488297  1
2010 Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, et al. Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. Human Genetics. 127: 469. PMID 21488277  1
2010 Foster ER, Campbell MC, Burack MA, Hartlein J, Flores HP, Cairns NJ, Hershey T, Perlmutter JS. Amyloid imaging of Lewy body-associated disorders. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2516-23. PMID 20922808 DOI: 10.1002/mds.23393  1
2010 Hershey T, Campbell MC, Videen TO, Lugar HM, Weaver PM, Hartlein J, Karimi M, Tabbal SD, Perlmutter JS. Mapping Go-No-Go performance within the subthalamic nucleus region. Brain : a Journal of Neurology. 133: 3625-34. PMID 20855421 DOI: 10.1093/brain/awq256  1
2010 Xu J, Hassanzadeh B, Chu W, Tu Z, Jones LA, Luedtke RR, Perlmutter JS, Mintun MA, Mach RH. [3H]4-(dimethylamino)-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)- butyl)benzamide: A selective radioligand for dopamine D3 receptors. II. Quantitative analysis of dopamine D3 and D2 receptor density ratio in the caudate-putamen Synapse. 64: 449-459. PMID 20175227 DOI: 10.1002/syn.20748  1
2010 Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Simon DK, Tarsy D, Hedera P, Truong DD, et al. Novel THAP1 sequence variants in primary dystonia. Neurology. 74: 229-38. PMID 20083799 DOI: 10.1212/WNL.0b013e3181ca00ca  1
2010 Burack MA, Hartlein J, Flores HP, Taylor-Reinwald L, Perlmutter JS, Cairns NJ. In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia. Neurology. 74: 77-84. PMID 20038776 DOI: 10.1212/WNL.0b013e3181c7da8e  1
2009 Paniello RC, Edgar JD, Perlmutter JS. Vocal exercise versus voice rest following botulinum toxin injections: A randomized crossover trial Annals of Otology, Rhinology and Laryngology. 118: 759-763. PMID 19999359  1
2009 Simón-Sánchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, Paisan-Ruiz C, Lichtner P, Scholz SW, Hernandez DG, Krüger R, Federoff M, Klein C, Goate A, Perlmutter J, et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nature Genetics. 41: 1308-12. PMID 19915575 DOI: 10.1038/ng.487  1
2009 Racette BA, Good LM, Kissel AM, Criswell SR, Perlmutter JS. A population-based study of parkinsonism in an Amish community. Neuroepidemiology. 33: 225-30. PMID 19641327 DOI: 10.1159/000229776  1
2009 Kumar N, Lee JJ, Perlmutter JS, Derdeyn CP. Cervical carotid and circle of Willis arterial anatomy of macaque monkeys: A comparative anatomy study Anatomical Record. 292: 976-984. PMID 19434671 DOI: 10.1002/ar.20891  1
2009 Xu J, Chu W, Tu Z, Jones LA, Luedtke RR, Perlmutter JS, Mintun MA, Mach RH. [3H]4-(dimethylamino)-N-[4-(4-(2-methoxyphenyl)piperazin-1-yl) butyl]benzamide, a selective radioligand for dopamine D3 receptors. I. In vitro characterization Synapse. 63: 717-728. PMID 19425052 DOI: 10.1002/syn.20652  1
2009 Xiao J, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Hedera P, Simon DK, Tarsy D, Truong DD, et al. High-throughput mutational analysis of TOR1A in primary dystonia. Bmc Medical Genetics. 10: 24. PMID 19284587 DOI: 10.1186/1471-2350-10-24  1
2009 Earhart GM, Clark BR, Tabbal SD, Perlmutter JS. Gait and balance in essential tremor: Variable effects of bilateral thalamic stimulation Movement Disorders. 24: 386-391. PMID 19006189 DOI: 10.1002/mds.22356  1
2009 Hong M, Perlmutter JS, Earhart GM. A kinematic and electromyographic analysis of turning in people with Parkinson disease Neurorehabilitation and Neural Repair. 23: 166-176. PMID 18981189 DOI: 10.1177/1545968308320639  1
2009 Patra B, Parsian AJ, Racette BA, Zhao JH, Perlmutter JS, Parsian A. LRRK2 gene G2019S mutation and SNPs [haplotypes] in subtypes of Parkinson's disease. Parkinsonism & Related Disorders. 15: 175-80. PMID 18752982 DOI: 10.1016/j.parkreldis.2008.05.004  1
2009 Perlmutter JS. Assessment of parkinson disease manifestations Current Protocols in Neuroscience. 10.1.1-10.1.14. DOI: 10.1002/0471142301.ns1001s49  1
2008 Torres-Russotto D, Perlmutter JS. Task-specific dystonias: A review Annals of the New York Academy of Sciences. 1142: 179-199. PMID 18990127 DOI: 10.1196/annals.1444.012  1
2008 Latourelle JC, Sun M, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, Shill HA, et al. The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study. Bmc Medicine. 6: 32. PMID 18986508 DOI: 10.1186/1741-7015-6-32  1
2008 Torres-Russotto D, Perlmutter JS. Focal Dystonias of the Hand and Upper Extremity Journal of Hand Surgery. 33: 1657-1658. PMID 18984354 DOI: 10.1016/j.jhsa.2008.09.001  1
2008 Ludlow CL, Adler CH, Berke GS, Bielamowicz SA, Blitzer A, Bressman SB, Hallett M, Jinnah HA, Juergens U, Martin SB, Perlmutter JS, Sapienza C, Singleton A, Tanner CM, Woodson GE. Research priorities in spasmodic dysphonia. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 139: 495-505. PMID 18922334 DOI: 10.1016/j.otohns.2008.05.624  1
2008 Karimi M, Golchin N, Tabbal SD, Hershey T, Videen TO, Wu J, Usche JW, Revilla FJ, Hartlein JM, Wernle AR, Mink JW, Perlmutter JS. Subthalamic nucleus stimulation-induced regional blood flow responses correlate with improvement of motor signs in Parkinson disease. Brain : a Journal of Neurology. 131: 2710-9. PMID 18697909 DOI: 10.1093/brain/awn179  1
2008 Campbell MC, Karimi M, Weaver PM, Wu J, Perantie DC, Golchin NA, Tabbal SD, Perlmutter JS, Hershey T. Neural correlates of STN DBS-induced cognitive variability in Parkinson disease. Neuropsychologia. 46: 3162-9. PMID 18682259 DOI: 10.1016/j.neuropsychologia.2008.07.012  1
2008 McNicoll CF, Latourelle JC, MacDonald ME, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, et al. Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1596-601. PMID 18649400 DOI: 10.1002/mds.22186  1
2008 DeStefano AL, Latourelle J, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts R, Guttman M, Racette BA, Perlmutter JS, Marlor L, Shill HA, et al. Replication of association between ELAVL4 and Parkinson disease: the GenePD study. Human Genetics. 124: 95-9. PMID 18587682 DOI: 10.1007/s00439-008-0526-4  1
2008 Powers WJ, Videen TO, Markham J, Black KJ, Golchin N, Perlmutter JS. Cerebral mitochondrial metabolism in early Parkinson's disease. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 28: 1754-60. PMID 18575458 DOI: 10.1038/jcbfm.2008.63  1
2008 Tobin JE, Latourelle JC, Lew MF, Klein C, Suchowersky O, Shill HA, Golbe LI, Mark MH, Growdon JH, Wooten GF, Racette BA, Perlmutter JS, Watts R, Guttman M, Baker KB, et al. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology. 71: 28-34. PMID 18509094 DOI: 10.1212/01.wnl.0000304051.01650.23  1
2008 Antenor-Dorsey JAV, Markham J, Moerlein SM, Videen TO, Perlmutter JS. Validation of the reference tissue model for estimation of dopaminergic D2-like receptor binding with [18F](N-methyl)benperidol in humans Nuclear Medicine and Biology. 35: 335-341. PMID 18355689 DOI: 10.1016/j.nucmedbio.2007.12.004  1
2008 Tabbal SD, Ushe M, Mink JW, Revilla FJ, Wernle AR, Hong M, Karimi M, Perlmutter JS. Unilateral subthalamic nucleus stimulation has a measurable ipsilateral effect on rigidity and bradykinesia in Parkinson disease. Experimental Neurology. 211: 234-42. PMID 18329019 DOI: 10.1016/j.expneurol.2008.01.024  1
2008 Hershey T, Wu J, Weaver PM, Perantie DC, Karimi M, Tabbal SD, Perlmutter JS. Unilateral vs. bilateral STN DBS effects on working memory and motor function in Parkinson disease. Experimental Neurology. 210: 402-8. PMID 18162183 DOI: 10.1016/j.expneurol.2007.11.011  1
2008 Antenor-Dorsey JAV, Laforest R, Moerlein SM, Videen TO, Perlmutter JS. Radiation dosimetry of N-([11C]methyl)benperidol as determined by whole-body PET imaging of primates European Journal of Nuclear Medicine and Molecular Imaging. 35: 771-778. PMID 18071701 DOI: 10.1007/s00259-007-0644-6  1
2008 Li Y, Grupe A, Rowland C, Holmans P, Segurado R, Abraham R, Jones L, Catanese J, Ross D, Mayo K, Martinez M, Hollingworth P, Goate A, Cairns NJ, Racette BA, ... Perlmutter JS, et al. Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's disease. Human Molecular Genetics. 17: 759-67. PMID 18063669 DOI: 10.1093/hmg/ddm348  1
2008 Videen TO, Campbell MC, Tabbal SD, Karimi M, Hershey T, Perlmutter JS. Validation of a fiducial-based atlas localization method for deep brain stimulation contacts in the area of the subthalamic nucleus. Journal of Neuroscience Methods. 168: 275-81. PMID 18061273 DOI: 10.1016/j.jneumeth.2007.10.007  1
2008 Foster ER, Black KJ, Antenor-Dorsey JA, Perlmutter JS, Hershey T. Motor asymmetry and substantia nigra volume are related to spatial delayed response performance in Parkinson disease. Brain and Cognition. 67: 1-10. PMID 18022303 DOI: 10.1016/j.bandc.2007.10.002  1
2007 Earhart GM, Hong M, Tabbal SD, Perlmutter JS. Effects of thalamic stimulation frequency on intention and postural tremor. Experimental Neurology. 208: 257-63. PMID 17920589 DOI: 10.1016/j.expneurol.2007.08.014  1
2007 Tabbal SD, Revilla FJ, Mink JW, Schneider-Gibson P, Wernle AR, de Erausquin GA, Perlmutter JS, Rich KM, Dowling JL. Safety and efficacy of subthalamic nucleus deep brain stimulation performed with limited intraoperative mapping for treatment of Parkinson's disease. Neurosurgery. 61: 119-27; discussion 1. PMID 17876242 DOI: 10.1227/01.neu.0000289725.97211.51  1
2007 Perlmutter JS, Thach WT. Writer's cramp: questions of causation. Neurology. 69: 331-2. PMID 17646624 DOI: 10.1212/01.wnl.0000269330.95232.7c  1
2007 Powers WJ, Haas RH, Le T, Videen TO, Hershey T, McGee-Minnich L, Perlmutter JS. Normal platelet mitochondrial complex I activity in Huntington's disease. Neurobiology of Disease. 27: 99-101. PMID 17543533 DOI: 10.1016/j.nbd.2007.04.008  1
2007 Hong M, Perlmutter JS, Earhart GM. Enhancement of rigidity in Parkinson's disease with activation. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 1164-8. PMID 17443709 DOI: 10.1002/mds.21524  1
2007 Tanner C, Comella C, Kamp C, Kieburtz K, Oakes D, Marshall F, Day D, Carter J, Pahwa R, Shoulson I, Truong D, Tran AH, Thompson K, Shulman LM, Rodriguez D, ... ... Perlmutter J, et al. Pramipexole in levodopa-treated Parkinson disease patients of African, Asian, and Hispanic heritage Clinical Neuropharmacology. 30: 72-85. PMID 17414939 DOI: 10.1097/01.wnf.0000240943.59617.4c  1
2007 Earhart GM, Stevens ES, Perlmutter JS, Hong M. Perception of active and passive turning in Parkinson disease. Neurorehabilitation and Neural Repair. 21: 116-22. PMID 17312086 DOI: 10.1177/1545968306290674  1
2007 Powers WJ, Videen TO, Markham J, McGee-Minnich L, Antenor-Dorsey JV, Hershey T, Perlmutter JS. Selective defect of in vivo glycolysis in early Huntington's disease striatum. Proceedings of the National Academy of Sciences of the United States of America. 104: 2945-9. PMID 17299049 DOI: 10.1073/pnas.0609833104  1
2007 Parsian AJ, Racette BA, Zhao JH, Sinha R, Patra B, Perlmutter JS, Parsian A. Association of α-synuclein gene haplotypes with Parkinson's disease Parkinsonism and Related Disorders. 13: 343-347. PMID 17292657 DOI: 10.1016/j.parkreldis.2006.12.006  1
2007 Hong M, Perlmutter JS, Earhart GM. Podokinetic after-rotation in Parkinson disease. Brain Research. 1128: 99-106. PMID 17140549 DOI: 10.1016/j.brainres.2006.10.053  1
2007 Racette BA, Bradley A, Wrisberg CA, Perlmutter JS. Reply from the authors [6] Neurology. 69: 495-496. DOI: 10.1212/01.wnl.0000279165.72261.d0  1
2007 Suchowersky O, Gronseth G, Perlmutter J, Reich S, Zesiewicz T, Weiner WJ. Appendix C: Practice parameter: Neuroprotective strategies and alternative therapies for Parkinson disease (an evidenced-based review): Report of the Quality Standards Subcommitte of the American Academy of Neurology Continuum Lifelong Learning in Neurology. 13: 170-176.  1
2006 Wilk JB, Tobin JE, Suchowersky O, Shill HA, Klein C, Wooten GF, Lew MF, Mark MH, Guttman M, Watts RL, Singer C, Growdon JH, Latourelle JC, Saint-Hilaire MH, DeStefano AL, ... ... Perlmutter JS, et al. Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study. Neurology. 67: 2206-10. PMID 17190945 DOI: 10.1212/01.wnl.0000249149.22407.d1  1
2006 Racette BA, Bradley A, Wrisberg CA, Perlmutter JS. The impact of litigation on neurologic research. Neurology. 67: 2124-8. PMID 17190932 DOI: 10.1212/01.wnl.0000249306.85048.86  1
2006 Perlmutter JS, Mink JW. Deep brain stimulation. Annual Review of Neuroscience. 29: 229-57. PMID 16776585 DOI: 10.1146/annurev.neuro.29.051605.112824  1
2006 Sun M, Latourelle JC, Wooten GF, Lew MF, Klein C, Shill HA, Golbe LI, Mark MH, Racette BA, Perlmutter JS, Parsian A, Guttman M, Nicholson G, Xu G, Wilk JB, et al. Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. Archives of Neurology. 63: 826-32. PMID 16769863 DOI: 10.1001/archneur.63.6.826  1
2006 Tabbal SD, Mink JW, Antenor JA, Carl JL, Moerlein SM, Perlmutter JS. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced acute transient dystonia in monkeys associated with low striatal dopamine. Neuroscience. 141: 1281-7. PMID 16766129 DOI: 10.1016/j.neuroscience.2006.04.072  1
2006 Ushe M, Mink JW, Tabbal SD, Hong M, Schneider Gibson P, Rich KM, Lyons KE, Pahwa R, Perlmutter JS. Postural tremor suppression is dependent on thalamic stimulation frequency. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1290-2. PMID 16685684 DOI: 10.1002/mds.20926  1
2006 Weiss EM, Hershey T, Karimi M, Racette B, Tabbal SD, Mink JW, Paniello RC, Perlmutter JS. Relative risk of spread of symptoms among the focal onset primary dystonias. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1175-81. PMID 16673404 DOI: 10.1002/mds.20919  1
2006 Karimi M, Carl JL, Loftin S, Perlmutter JS. Modified high-performance liquid chromatography with electrochemical detection method for plasma measurement of levodopa, 3-O-methyldopa, dopamine, carbidopa and 3,4-dihydroxyphenyl acetic acid. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 836: 120-3. PMID 16584928 DOI: 10.1016/j.jchromb.2006.03.027  1
2006 Racette BA, Good L, Antenor JA, McGee-Minnich L, Moerlein SM, Videen TO, Perlmutter JS. [18F]FDOPA PET as an endophenotype for Parkinson's Disease linkage studies. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 141: 245-9. PMID 16528749 DOI: 10.1002/ajmg.b.30293  1
2006 Racette BA, Tabbal SD, Jennings D, Good LM, Perlmutter JS, Evanoff BA. A rapid method for mass screening for parkinsonism. Neurotoxicology. 27: 357-61. PMID 16376428 DOI: 10.1016/j.neuro.2005.11.005  1
2006 Racette BA, Perlmutter JS, Evanoff BA. Reply from the Authors [12] Neurology. 66: 617. DOI: 10.1212/01.wnl.0000216108.57529.b1  1
2005 Karamohamed S, Latourelle JC, Racette BA, Perlmutter JS, Wooten GF, Lew M, Klein C, Shill H, Golbe LI, Mark MH, Guttman M, Nicholson G, Wilk JB, Saint-Hilaire M, DeStefano AL, et al. BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study. Neurology. 65: 1823-5. PMID 16344533 DOI: 10.1212/01.wnl.0000187075.81589.fd  1
2005 Sinha R, Racette B, Perlmutter JS, Parsian A. Prevalence of parkin gene mutations and variations in idiopathic Parkinson's disease Parkinsonism and Related Disorders. 11: 341-347. PMID 16019250 DOI: 10.1016/j.parkreldis.2005.04.003  1
2005 Karamohamed S, Golbe LI, Mark MH, Lazzarini AM, Suchowersky O, Labelle N, Guttman M, Currie LJ, Wooten GF, Stacy M, Saint-Hilaire M, Feldman RG, Liu J, Shoemaker CM, Wilk JB, ... ... Perlmutter JS, et al. Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 1188-91. PMID 15966003 DOI: 10.1002/mds.20515  1
2005 Racette BA, Tabbal SD, Jennings D, Good L, Perlmutter JS, Evanoff B. Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders Neurology. 64: 230-235. PMID 15668418  1
2005 Racette BA, Antenor JA, McGee-Minnich L, Moerlein SM, Videen TO, Kotagal V, Perlmutter JS. [18F]FDOPA PET and clinical features in parkinsonism due to manganism. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 492-6. PMID 15648057 DOI: 10.1002/mds.20381  1
2005 Black KJ, Hershey T, Hartlein JM, Carl JL, Perlmutter JS. Levodopa challenge neuroimaging of levodopa-related mood fluctuations in Parkinson's disease. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 590-601. PMID 15602502 DOI: 10.1038/sj.npp.1300632  1
2005 Perlmutter JS, Tabbal SD. MPTP-Induced nigrostriatal injury in nonhuman primates Movement Disorders. 139-148. DOI: 10.1016/B978-012088382-0/50011-6  1
2004 van Mier HI, Perlmutter JS, Petersen SE. Functional changes in brain activity during acquisition and practice of movement sequences. Motor Control. 8: 500-20. PMID 15585904  1
2004 Racette BA, Esper GJ, Antenor J, Black KJ, Burkey A, Moerlein SM, Videen TO, Kotagal V, Ojemann JG, Perlmutter JS. Pathophysiology of parkinsonism due to hydrocephalus. Journal of Neurology, Neurosurgery, and Psychiatry. 75: 1617-9. PMID 15489399 DOI: 10.1136/jnnp.2003.028449  1
2004 Ushe M, Mink JW, Revilla FJ, Wernle A, Schneider Gibson P, McGee-Minnich L, Hong M, Rich KM, Lyons KE, Pahwa R, Perlmutter JS. Effect of stimulation frequency on tremor suppression in essential tremor. Movement Disorders : Official Journal of the Movement Disorder Society. 19: 1163-8. PMID 15390071 DOI: 10.1002/mds.20231  1
2004 Pastor P, Ezquerra M, Perez JC, Chakraverty S, Norton J, Racette BA, McKeel D, Perlmutter JS, Tolosa E, Goate AM. Novel haplotypes in 17q21 are associated with progressive supranuclear palsy. Annals of Neurology. 56: 249-58. PMID 15293277 DOI: 10.1002/ana.20178  1
2004 Hershey T, Black KJ, Hartlein J, Braver TS, Barch DM, Carl JL, Perlmutter JS. Dopaminergic modulation of response inhibition: an fMRI study. Brain Research. Cognitive Brain Research. 20: 438-48. PMID 15268921 DOI: 10.1016/j.cogbrainres.2004.03.018  1
2004 Black KJ, Koller JM, Snyder AZ, Perlmutter JS. Atlas template images for nonhuman primate neuroimaging: baboon and macaque. Methods in Enzymology. 385: 91-102. PMID 15130735 DOI: 10.1016/S0076-6879(04)85006-7  1
2004 Parsian A, Sinha R, Racette B, Zhao JH, Perlmutter JS. Association of a variation in the promoter region of the brain-derived neurotrophic factor gene with familial Parkinson's disease Parkinsonism and Related Disorders. 10: 213-219. PMID 15120095 DOI: 10.1016/j.parkreldis.2003.12.003  1
2004 Hershey T, Black KJ, Hartlein JM, Barch DM, Braver TS, Carl JL, Perlmutter JS. Cognitive-pharmacologic functional magnetic resonance imaging in tourette syndrome: a pilot study. Biological Psychiatry. 55: 916-25. PMID 15110735 DOI: 10.1016/j.biopsych.2004.01.003  1
2004 Hershey T, Revilla FJ, Wernle A, Gibson PS, Dowling JL, Perlmutter JS. Stimulation of STN impairs aspects of cognitive control in PD. Neurology. 62: 1110-4. PMID 15079009  1
2004 Parsian A, Racette B, Zhang ZH, Rundle M, Perlmutter JS. Association of variations in monoamine oxidases A and B with Parkinson's disease subgroups Genomics. 83: 454-460. PMID 14962671 DOI: 10.1016/j.ygeno.2003.09.002  1
2004 Perlmutter JS, Mink JW. Dysfunction of dopaminergic pathways in dystonia. Advances in Neurology. 94: 163-70. PMID 14509670  1
2004 Moerlein SM, Perlmutter JS, Welch MJ. Radiosynthesis of (N-[11C]methyl)benperidol for PET investigation of D2 receptor binding Radiochimica Acta. 92: 333-339. DOI: 10.1524/ract.92.4.333.35584  1
2003 Karamohamed S, DeStefano AL, Wilk JB, Shoemaker CM, Golbe LI, Mark MH, Lazzarini AM, Suchowersky O, Labelle N, Guttman M, Currie LJ, Wooten GF, Stacy M, Saint-Hilaire M, Feldman RG, ... ... Perlmutter JS, et al. A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study. Neurology. 61: 1557-61. PMID 14663042 DOI: 10.1212/01.WNL.0000095966.99430.F4  1
2003 Hershey T, Revilla FJ, Wernle AR, McGee-Minnich L, Antenor JV, Videen TO, Dowling JL, Mink JW, Perlmutter JS. Cortical and subcortical blood flow effects of subthalamic nucleus stimulation in PD. Neurology. 61: 816-21. PMID 14504327  1
2003 Racette BA, Good L, Sagitto S, Perlmutter JS. Botulinum toxin B reduces sialorrhea in parkinsonism. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 1059-61. PMID 14502678 DOI: 10.1002/mds.10484  0.76
2003 Bastian AJ, Kelly VE, Perlmutter JS, Mink JW. Effects of pallidotomy and levodopa on walking and reaching movements in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 1008-17. PMID 14502668 DOI: 10.1002/mds.10494  1
2003 Bastian AJ, Kelly VE, Revilla FJ, Perlmutter JS, Mink JW. Different effects of unilateral versus bilateral subthalamic nucleus stimulation on walking and reaching in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 1000-7. PMID 14502667 DOI: 10.1002/mds.10493  1
2003 Kaufman JA, Phillips-Conroy JE, Black KJ, Perlmutter JS. Asymmetric regional cerebral blood flow in sedated baboons measured by positron emission tomography (PET). American Journal of Physical Anthropology. 121: 369-77. PMID 12884319 DOI: 10.1002/ajpa.10181  1
2003 Black KJ, Carl JL, Hartlein JM, Warren SL, Hershey T, Perlmutter JS. Rapid intravenous loading of levodopa for human research: clinical results. Journal of Neuroscience Methods. 127: 19-29. PMID 12865145 DOI: 10.1016/S0165-0270(03)00096-7  1
2003 Hershey T, Black KJ, Carl JL, McGee-Minnich L, Snyder AZ, Perlmutter JS. Long term treatment and disease severity change brain responses to levodopa in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 74: 844-51. PMID 12810765 DOI: 10.1136/jnnp.74.7.844  1
2003 Evinger C, Perlmutter JS. Blind men and blinking elephants. Neurology. 60: 1732-3. PMID 12796520  1
2002 Black KJ, Hershey T, Koller JM, Videen TO, Mintun MA, Price JL, Perlmutter JS. A possible substrate for dopamine-related changes in mood and behavior: prefrontal and limbic effects of a D3-preferring dopamine agonist. Proceedings of the National Academy of Sciences of the United States of America. 99: 17113-8. PMID 12482941 DOI: 10.1073/pnas.012260599  1
2002 Racette BA, Lopate G, Good L, Sagitto S, Perlmutter JS. Ptosis as a remote effect of therapeutic botulinum toxin B injection Neurology. 59: 1445-1447. PMID 12427903  1
2002 Racette BA, Hartlein JM, Hershey T, Mink JW, Perlmutter JS, Black KJ. Clinical features and comorbidity of mood fluctuations in Parkinson's disease. The Journal of Neuropsychiatry and Clinical Neurosciences. 14: 438-42. PMID 12426412 DOI: 10.1176/appi.neuropsych.14.4.438  1
2002 Shults CW, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S, Juncos JL, Nutt J, Shoulson I, Carter J, Kompoliti K, Perlmutter JS, Reich S, Stern M, Watts RL, et al. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Archives of Neurology. 59: 1541-50. PMID 12374491 DOI: 10.1001/archneur.59.10.1541  1
2002 Racette BA, Stambuk M, Perlmutter JS. Secondary nonresponsiveness to new bulk botulinum toxin A (BCB2024). Movement Disorders : Official Journal of the Movement Disorder Society. 17: 1098-100. PMID 12360571 DOI: 10.1002/mds.10209  1
2002 Perlmutter JS, Mink JW, Bastian AJ, Zackowski K, Hershey T, Miyawaki E, Koller W, Videen TO. Blood flow responses to deep brain stimulation of thalamus. Neurology. 58: 1388-94. PMID 12011286  1
2002 Racette BA, Rundle M, Wang JC, Goate A, Saccone NL, Farrer M, Lincoln S, Hussey J, Smemo S, Lin J, Suarez B, Parsian A, Perlmutter JS. A multi-incident, Old-Order Amish family with PD. Neurology. 58: 568-74. PMID 11865134  1
2002 Parsian A, Racette B, Goldsmith LJ, Perlmutter JS. Parkinson's disease and apolipoprotein E: Possible association with dementia but not age at onset Genomics. 79: 458-461. PMID 11863377 DOI: 10.1006/geno.2002.6707  1
2002 Zackowski KM, Bastian AJ, Hakimian S, Mink JW, Perlmutter JS, Koller WC, Thach WT. Thalamic stimulation reduces essential tremor but not the delayed antagonist muscle timing. Neurology. 58: 402-10. PMID 11839839  1
2001 Racette BA, Perry A, D'Avossa G, Perlmutter JS. Late-onset neurodegeneration with brain iron accumulation type 1: Expanding the clinical spectrum Movement Disorders. 16: 1148-1152. PMID 11748751 DOI: 10.1002/mds.10012  1
2001 Black KJ, Koller JM, Snyder AZ, Perlmutter JS. Template images for nonhuman primate neuroimaging: 2. Macaque. Neuroimage. 14: 744-8. PMID 11506546 DOI: 10.1006/nimg.2001.0871  1
2001 Black KJ, Snyder AZ, Koller JM, Gado MH, Perlmutter JS. Template images for nonhuman primate neuroimaging: 1. Baboon. Neuroimage. 14: 736-43. PMID 11506545 DOI: 10.1006/nimg.2001.0752  1
2001 Racette BA, McGee-Minnich L, Moerlein SM, Mink JW, Videen TO, Perlmutter JS. Welding-related parkinsonism: clinical features, treatment, and pathophysiology. Neurology. 56: 8-13. PMID 11148228 DOI: 10.1212/WNL.56.1.8  1
2000 Hershey T, Black KJ, Carl JL, Perlmutter JS. Dopa-induced blood flow responses in nonhuman primates. Experimental Neurology. 166: 342-9. PMID 11085899 DOI: 10.1006/exnr.2000.7522  1
2000 Racette BA. Chorea and jaw-opening dystonia as a manifestation of NeuroBehcet's syndrome Movement Disorders. 15: 741-744. PMID 10928591 DOI: 10.1002/1531-8257(200007)15:4<741::AID-MDS1025>3.0.CO;2-5  0.76
2000 Black KJ, Hershey T, Gado MH, Perlmutter JS. Dopamine D(1) agonist activates temporal lobe structures in primates. Journal of Neurophysiology. 84: 549-57. PMID 10899226  1
2000 Miyawaki E, Perlmutter JS, Tröster AI, Videen TO, Koller WC. The behavioral complications of pallidal stimulation: A case report Brain and Cognition. 42: 417-434. PMID 10753488 DOI: 10.1006/brcg.1999.1113  1
1999 Racette BA, McGee-Minnich L, Perlmutter JS. Efficacy and safety of a new bulk toxin of botulinum toxin in cervical dystonia: A blinded evaluation Clinical Neuropharmacology. 22: 337-339. PMID 10626093  1
1999 Racette BA, Gokden MS, Tychsen LS, Perlmutter JS. Convergence insufficiency in idiopathic Parkinson's disease responsive to levodopa. Strabismus. 7: 169-74. PMID 10520242  1
1999 Landau WM, Perlmutter JS. Transient acute depression induced by high-frequency deep-brain stimulation. The New England Journal of Medicine. 341: 1004. PMID 10498482 DOI: 10.1056/NEJM199909233411316  1
1999 Bezerra MLS, Martinez JVL, Nasser JA, Kumar R, Krack P, Pollak P, Landau WM, Perlmutter JS, Bejjani BP, Damier P, Agid Y. Transient acute depression induced by high-frequency deep-brain stimulation [3] (multiple letters) New England Journal of Medicine. 341: 1003-1004. PMID 10498480 DOI: 10.1056/NEJM199909233411315  1
1999 Racette BA, Rundle M, Parsian A, Perlmutter JS. Evaluation of a screening questionnaire for genetic studies of Parkinson's disease American Journal of Medical Genetics - Neuropsychiatric Genetics. 88: 539-543. PMID 10490713 DOI: 10.1002/(SICI)1096-8628(19991015)88:5<539::AID-AJMG19>3.0.CO;2-S  1
1999 Perlmutter JS, Moerlein SM. Pet measurements of dopaminergic pathways in the brain Quarterly Journal of Nuclear Medicine. 43: 140-154. PMID 10429509  1
1999 Feiwell RJ, Black KJ, McGee-Minnich LA, Snyder AZ, MacLeod AM, Perlmutter JS. Diminished regional cerebral blood flow response to vibration in patients with blepharospasm Neurology. 52: 291-297. PMID 9932946  1
1998 Parsian A, Racette B, Zhang ZH, Chakraverty S, Rundle M, Goate A, Perlmutter JS. Mutation, sequence analysis, and association studies of α-synuclein in Parkinson's disease Neurology. 51: 1757-1759. PMID 9855543  1
1998 van Mier H, Tempel LW, Perlmutter JS, Raichle ME, Petersen SE. Changes in brain activity during motor learning measured with PET: effects of hand of performance and practice. Journal of Neurophysiology. 80: 2177-99. PMID 9772270  1
1998 Racette BA, Perlmutter JS. Levodopa responsive parkinsonism in an adult with Huntington's disease Journal of Neurology Neurosurgery and Psychiatry. 65: 577-579. PMID 9771791  1
1998 Hershey T, Black KJ, Stambuk MK, Carl JL, McGee-Minnich LA, Perlmutter JS. Altered thalamic response to levodopa in Parkinson's patients with dopa-induced dyskinesias. Proceedings of the National Academy of Sciences of the United States of America. 95: 12016-21. PMID 9751782 DOI: 10.1073/pnas.95.20.12016  1
1998 Black KJ, Ongür D, Perlmutter JS. Putamen volume in idiopathic focal dystonia. Neurology. 51: 819-24. PMID 9748033  1
1998 Black KJ, Racette B, Perlmutter JS. Preventing contractions in neuroleptic malignant syndrome and dystonia [2] American Journal of Psychiatry. 155: 1298-1299. PMID 9734560  1
1998 Todd RD, Perlmutter JS. Mutational and biochemical analysis of dopamine in dystonia: Evidence for decreased dopamine D2 receptor inhibition Molecular Neurobiology. 16: 135-147. PMID 9588625 DOI: 10.1007/BF02740641  1
1998 Racette BA, Lauryssen C, Perlmutter JS. Preoperative treatment with botulinum toxin to facilitate cervical fusion in dystonic cerebral palsy. Report of two cases Journal of Neurosurgery. 88: 328-330. PMID 9452245  1
1998 Moerlein SM, Mintun MA, Perlmutter JS, Welch MJ, Siegel BA. USP tandards for flumazenil c 11 injection Pharmacopeial Forum. 24: 6360-6365.  1
1997 Black KJ, Gado MH, Videen TO, Perlmutter JS. Baboon basal ganglia stereotaxy using internal MRI landmarks: Validation and application to PET imaging Journal of Computer Assisted Tomography. 21: 881-886. PMID 9386276 DOI: 10.1097/00004728-199711000-00006  1
1997 Perlmutter JS, Tempel LW, Black KJ, Parkinson D, Todd RD. MPTP induces dystonia and parkinsonism: Clues to the pathophysiology of dystonia Neurology. 49: 1432-1438. PMID 9371934 DOI: 10.1212/WNL.49.5.1432  1
1997 Moerlein SM, Perlmutter JS, Markham J, Welch MJ. In vivo kinetics of [18F](N-methyl)benperidol: A novel PET tracer for assessment of dopaminergic D2-like receptor binding Journal of Cerebral Blood Flow and Metabolism. 17: 833-845. PMID 9290581 DOI: 10.1097/00004647-199708000-00002  1
1997 Moerlein SM, Perlmutter JS, Cutler PD, Welch MJ. Radiation dosimetry of [18F](N-methyl)benperidol as determined by whole-body PET imaging of primates Nuclear Medicine and Biology. 24: 311-318. PMID 9257329 DOI: 10.1016/S0969-8051(97)00042-5  1
1996 Black KJ, Videen TO, Perlmutter JS. A metric for testing the accuracy of cross-modality image registration: Validation and application Journal of Computer Assisted Tomography. 20: 855-861. PMID 8797932 DOI: 10.1097/00004728-199609000-00038  1
1995 Moerlein SM, Perlmutter JS, Welch MJ. Specific, reversible binding of [18F]benperidol to baboon D2 receptors: PET evaluation of an improved 18F-labeled ligand Nuclear Medicine and Biology. 22: 809-815. PMID 8535343 DOI: 10.1016/0969-8051(95)00022-P  1
1994 Moerlein SM, Perlmutter JS, Welch MJ, Raichle ME. First-pass extraction fraction of iodine-123 labeled perfusion tracers in living primate brain. Nuclear Medicine and Biology. 21: 847-55. PMID 9234334 DOI: 10.1016/0969-8051(94)90164-3  1
1994 Larson KB, Perman WH, Perlmutter JS, Gado MH, Ollinger JM, Zierler K. Tracer-kinetic analysis for measuring regional cerebral blood flow by dynamic nuclear magnetic resonance imaging Journal of Theoretical Biology. 170: 1-14. PMID 7967632 DOI: 10.1006/jtbi.1994.1164  1
1992 Moerlein SM, Perlmutter JS. Binding of 5-(2′-[18F]fluoroenthyl)flumazenil to central benzodiazepine receptors measured in living baboon by positron emission tomography European Journal of Pharmacology. 218: 109-115. PMID 1327820 DOI: 10.1016/0014-2999(92)90153-U  1
1992 Moerlein SM, Perlmutter JS. Specific binding of 3N-(2′-[18F]fluoroethyl)benperidol to primate cerebral dopaminergic D2 receptors demonstrated in vivo by PET Neuroscience Letters. 148: 97-100. PMID 1300511 DOI: 10.1016/0304-3940(92)90813-M  1
1991 Moerlein SM, Perlmutter JS. Central serotonergic S2 binding in Papio anubis measured in vivo with N-ω-[18F]fluoroethylketanserin and PET Neuroscience Letters. 123: 23-26. PMID 2062450 DOI: 10.1016/0304-3940(91)90149-N  1
1988 Videen TO, Perlmutter JS, Mintun MA, Raichle ME. Regional correction of positron emission tomography data for the effects of cerebral atrophy. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 8: 662-70. PMID 3262114 DOI: 10.1038/jcbfm.1988.113  1
1988 Welch MJ, Katzenellenbogen JA, Mathias CJ, Brodack JW, Carlson KE, Chi DY, Dence CS, Kilbourn MR, Perlmutter JS, Raichle ME. N-(3-[18F]fluoropropyl)-spiperone: the preferred 18F labeled spiperone analog for positron emission tomographic studies of the dopamine receptor. International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology. 15: 83-97. PMID 3258305 DOI: 10.1016/0883-2897(88)90164-X  1
1987 Perlmutter JS, Kilbourn MR, Raichle ME, Welch MJ. MPTP-induced up-regulation of in vivo dopaminergic radioligand-receptor binding in humans. Neurology. 37: 1575-9. PMID 3498914 DOI: 10.1212/WNL.37.10.1575  1
1987 Videen TO, Perlmutter JS, Herscovitch P, Raichle ME. Brain blood volume, flow, and oxygen utilization measured with 15O radiotracers and positron emission tomography: revised metabolic computations. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 7: 513-6. PMID 3497165 DOI: 10.1038/jcbfm.1987.97  1
1987 Perlmutter JS, Powers WJ, Herscovitch P, Fox PT, Raichle ME. Regional asymmetries of cerebral blood flow, blood volume, and oxygen utilization and extraction in normal subjects. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 7: 64-7. PMID 3492507 DOI: 10.1038/jcbfm.1987.9  0.48
1986 Reiman EM, Raichle ME, Robins E, Butler FK, Herscovitch P, Fox P, Perlmutter J. The application of positron emission tomography to the study of panic disorder. The American Journal of Psychiatry. 143: 469-77. PMID 3485385 DOI: 10.1176/ajp.143.4.469  1
1986 Perlmutter JS, Raichle ME. In vitro or in vivo receptor binding: where does the truth lie? Annals of Neurology. 19: 384-5. PMID 3010801 DOI: 10.1002/ana.410190413  1
1985 Fox PT, Perlmutter JS, Raichle ME. A stereotactic method of anatomical localization for positron emission tomography. Journal of Computer Assisted Tomography. 9: 141-53. PMID 3881487 DOI: 10.1097/00004728-198501000-00025  1
1985 Perlmutter JS, Herscovitch P, Powers WJ, Fox PT, Raichle ME. Standardized mean regional method for calculating global positron emission tomographic measurements. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 5: 476-80. PMID 3875621 DOI: 10.1038/jcbfm.1985.66  0.48
1985 Perlmutter JS, Raichle ME. Regional blood flow in hemiparkinsonism. Neurology. 35: 1127-34. PMID 3875059 DOI: 10.1212/WNL.35.8.1127  1
1984 Raichle ME, Perlmutter JS, Fox PT. Parkinson's disease: metabolic and pharmacological approaches with positron emission tomography. Annals of Neurology. 15: S131-2. PMID 6611113 DOI: 10.1002/ana.410150725  1
1984 Perlmutter JS, Raichle ME. Pure hemidystonia with basal ganglion abnormalities on positron emission tomography. Annals of Neurology. 15: 228-33. PMID 6609680 DOI: 10.1002/ana.410150303  1
1984 Fox PT, Perlmutter JS, Raichle ME. Stereotactic method for determining anatomical localization in physiological brain images. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 4: 634. PMID 6389580 DOI: 10.1038/jcbfm.1984.91  1
Show low-probability matches.